J 2023

Is breastfeeding in MS harmful or not? An answer from real-world Czech data

HRADILEK, Pavel, Olga ZAPLETALOVA, Petra HANULIKOVA, Eva KUBALA HAVRDOVA, Ivana WOZNICOVA et. al.

Základní údaje

Originální název

Is breastfeeding in MS harmful or not? An answer from real-world Czech data

Autoři

HRADILEK, Pavel (203 Česká republika), Olga ZAPLETALOVA (203 Česká republika), Petra HANULIKOVA (203 Česká republika), Eva KUBALA HAVRDOVA (203 Česká republika), Ivana WOZNICOVA (203 Česká republika), Aneta MAZOUCHOVA (203 Česká republika), Jiri DRAHOTA (203 Česká republika), Michal LAUER (203 Česká republika), Ivana STETKAROVA (203 Česká republika), Martin VALIS (203 Česká republika), Jana LIBERTINOVA (203 Česká republika), Pavel ŠTOURAČ (203 Česká republika, domácí), Jana ADAMKOVA (203 Česká republika), Radek AMPAPA (203 Česká republika), Marta VACHOVA (203 Česká republika), Michal DUFEK (203 Česká republika), Alena MARTINKOVA (203 Česká republika), Marek PETERKA (203 Česká republika), Eva RECMANOVA (203 Česká republika), Jan MARES (203 Česká republika) a Dana HORAKOVA (203 Česká republika)

Vydání

MULTIPLE SCLEROSIS AND RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2023, 2211-0348

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.000 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133298

Organizační jednotka

Lékařská fakulta

UT WoS

001032690900001

Klíčová slova anglicky

Multiple sclerosis; Breastfeeding; EDSS; Relapses; Czech national multiple sclerosis patient registry ReMuS

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 29. 1. 2024 14:33, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: The influence of breastfeeding and it & PRIME;s duration on the course of multiple sclerosis (MS) is unclear. Here we analyzed a real-world data for breastfeeding women with MS and their disease course collected from a Czech national registry ReMuS.Objectives: To identify risk factors associated with not initiating breastfeeding after delivery, to analyze the impact of breastfeeding on the MS disease course, evaluate the assumption, that breastfeeding is not harmful in MS patients, and compare the disease course by breastfeeding status.Materials and methods: Using propensity score matching we compared Expanded Disability Status Scale (EDSS), confirmed disease worsening (CDW) and annual relapse rate (ARR) in breastfeeding and non-breastfeeding MS patients according to disease duration, disease modifying treatment (DMT) before pregnancy, last EDSS score before conception, age, and ARR during pregnancy. We also compared these parameters between breastfeeding patients not using a DMT and non-breastfeeding patients who resumed DMT within 3 months after delivery. EDSS, ARR, and CDW were collected at 12, 24, and 36 months after delivery.Results: A total of 1681 pregnancies that ended in delivery were analyzed from 2013 through 2020. Change in ARR and EDSS values and 6-months CDW did not significantly differ between the analyzed groups. Compared with non-breastfeeding women who resumed DMT early after delivery, breastfeeding women with MS did not experience worse clinical outcomes even without initiating a DMT. Discussion: Breastfeeding in Czech women with MS did not negatively affect the disease course and can be supported. Patients with MS can be treated with certain DMTs alongside breastfeeding and there is no need to stop breastfeeding, if the patient is clinically stable.